(Q52625009)
Statements
A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin (English)
scientific article published on 27 April 2012
No description defined